These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Large accelerated filer
|
o |
Accelerated filed
|
o |
| Non-accelerated filer | o | Smaller reporting company | x |
|
Page
|
|||||
|
|
|||||
| Item 1. |
Financial Statements
(Unaudited)
|
||||
|
Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012 (Unaudited)
|
3 | ||||
|
Consolidated
Statements of Operations for the Three and Six Months Ended June 30, 2013 and 20
12 (Unaudited)
|
4 | ||||
|
Consolidated
Statements of Cash Flows for the Six Months Ended June 30, 2013 and 20
12 (Unaudited)
|
5 | ||||
|
Notes to Consolidated Financial Statements
(Unaudited)
|
6 | ||||
| Item 2. |
Management’s Discussion and Analysis and Plan of Operation
|
12 | |||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
14 | |||
| Item 4T. |
Controls and Procedures
|
14 | |||
|
|
|||||
| Item 1. |
Legal Proceedings
|
15 | |||
| Item 1A. |
Risk Factors
|
15 | |||
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
15 | |||
| Item 3. |
Defaults upon Senior Securities
|
15 | |||
| Item 4. |
Mine Safety Information
|
15 | |||
| Item 5. |
Other Information
|
15 | |||
| Item 6. |
Exhibits
|
16 | |||
| Signatures | 17 | ||||
|
June 30,
2013
|
December 31,
2012
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 7,010 | $ | 1,209 | ||||
|
Marketable securities
|
87,750 | 105,000 | ||||||
|
Accounts receivable
|
1,500 | - | ||||||
|
Prepaid expenses
|
- | 35,000 | ||||||
|
Total current assets
|
96,260 | 141,209 | ||||||
|
Property and equipment, net of accumulated depreciation
$66,460 and $54,654 respectively
|
7,481 | 19,286 | ||||||
|
Equity method investments held in related party
|
-- | 132,988 | ||||||
|
Total Assets
|
$ | 103,741 | $ | 293,483 | ||||
|
|
||||||||
|
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 145,071 | $ | 132,002 | ||||
|
Notes payable
|
1,250 | 2,000 | ||||||
|
Notes payable to related parties
|
106,619 | 109,819 | ||||||
|
Total current liabilities
|
252,940 | 243,821 | ||||||
|
Stockholders’ Equity (Deficit):
|
||||||||
|
Preferred stock; $0.001 par value, 10,000,000 shares
authorized, 9,000,000 undesignated authorized
|
-- | |||||||
|
Series A convertible preferred stock; $0.001 par value,
1,000,000 shares authorized, none issued or outstanding
|
-- | -- | ||||||
|
Common stock; $0.001 par value, 4,900,000,000 shares
authorized, 878,192,504 and 880,325,835 shares issued
and outstanding, respectively
|
878,193 | 880,326 | ||||||
|
Additional paid-in capital
|
7,940,951 | 7,938,818 | ||||||
|
Accumulated deficit
|
(8,968,343 | ) | (8,769,482 | ) | ||||
|
Total stockholders’ (deficit) equity
|
(149,199 | ) | 49,662 | |||||
|
Total Liabilities and Stockholders’ (Deficit) Equity
|
$ | 103,741 | $ | 293,483 | ||||
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
|||||||||||||
|
(Restated)
|
(Restated)
|
|||||||||||||||
|
Revenue
|
$ | 16,080 | $ | 20,281 | $ | 44,380 | $ | 22,495 | ||||||||
|
Direct material costs
|
48 | 1,656 | 151 | 4,303 | ||||||||||||
|
|
||||||||||||||||
|
Operating Expenses:
|
||||||||||||||||
|
General and administrative
|
28,023 | 51,887 | 49,369 | 320,219 | ||||||||||||
|
Depreciation
|
5,237 | 1,880 | 11,806 | 3,760 | ||||||||||||
|
Loss from operations
|
(17,228 | ) | (35,142 | ) | (16,946 | ) | (305,787 | ) | ||||||||
|
|
||||||||||||||||
|
Other Income (Expenses):
|
||||||||||||||||
|
Other income
|
893 | -- | 2,661 | 1,275 | ||||||||||||
|
Realized loss on marketable securities
|
-- | (1,155 | ) | -- | (1,155 | ) | ||||||||||
|
Unrealized (loss) gain on marketable securities
|
(6,250 | ) | 2,400 | (42,800 | ) | 28,000 | ||||||||||
|
Loss on equity method investment in related party
|
(80,348 | ) | (33,652 | ) | (132,988 | ) | (47,681 | ) | ||||||||
|
Interest expense
|
(4,284 | ) | (2,856 | ) | (8,568 | ) | (5,972 | ) | ||||||||
|
Loss on extinguishment of debt
|
-- | (17,700 | ) | -- | (17,700 | ) | ||||||||||
|
Impairment of equity method investment
|
-- | -- | -- | (172,617 | ) | |||||||||||
|
Other expense
|
(190 | ) | (1,154 | ) | (220 | ) | (697 | ) | ||||||||
|
Total other expenses
|
(90,179 | ) | (54,117 | ) | (181,915 | ) | (216,547 | ) | ||||||||
|
Net loss
|
$ | (107,407 | ) | $ | (89,259 | ) | $ | (198,861 | ) | $ | (522,334 | ) | ||||
|
|
||||||||||||||||
|
Net loss per common share attributable to common
stockholders (basic and diluted)
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||
|
Weighted average common shares outstanding
(basic and diluted)
|
878,286,275 | 861,872,576 | 879,300,421 | 802,992,815 | ||||||||||||
|
Six Months Ended
|
||||||||
|
June 30,
|
||||||||
|
|
2013
|
2012
|
||||||
|
(Restated)
|
||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
|
Net loss
|
$ | (198,861 | ) | $ | (522,334 | ) | ||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation expense
|
11,806 | 3,760 | ||||||
|
Common stock issued for services
|
-- | 219,851 | ||||||
|
Unrealized loss (gain) on marketable securities
|
42,800 | (28,000 | ) | |||||
|
Impairment of equity method investments in related party
|
-- | 172,617 | ||||||
|
Loss on equity method investments in related party
|
132,988 | 47,681 | ||||||
|
Loss on extinguishment of debt
|
-- | 17,700 | ||||||
|
Realized (gain) loss on securities
|
-- | 1,155 | ||||||
|
Marketable securities received for revenue
|
(25,550 | ) | -- | |||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(1,500 | ) | 25 | |||||
|
Prepaid expenses
|
35,000 | -- | ||||||
|
Accounts payable and accrued expenses
|
13,068 | (67,064 | ) | |||||
|
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
9,751 | (154,609 | ) | |||||
|
|
||||||||
|
CASH FLOWS USED IN INVESTING ACTIVITIES
|
||||||||
|
Proceeds from the sale of marketable securities
|
-- | 4,245 | ||||||
|
Cash paid for purchase of fixed assets
|
-- | (51 | ) | |||||
|
NET CASH PROVIDED BY INVESTING ACTIVITIES
|
-- | 4,194 | ||||||
|
|
||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Proceeds from the sale of common stock
|
-- | 10,000 | ||||||
|
Payments on notes payable
|
(2,000 | ) | -- | |||||
|
Payments on related party notes payable
|
(4,000 | ) | -- | |||||
|
Borrowings on notes payable
|
1,250 | 59,000 | ||||||
|
Borrowings on related party notes payable
|
800 | 8,200 | ||||||
|
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES
|
(3,950 | ) | 77,200 | |||||
|
Net increase (decrease) in cash
|
5,801 | (73,215 | ) | |||||
|
Cash, beginning of period
|
1,209 | 84,325 | ||||||
|
Cash, end of period
|
$ | 7,010 | $ | 11,110 | ||||
|
SUPPLEMENTAL CASH FLOWS INFORMATION
|
||||||||
|
Interest paid
|
$ | -- | $ | 13 | ||||
|
Income taxes paid
|
-- | -- | ||||||
|
Noncash Investing and Financing Activities:
|
||||||||
|
Common stock returned and cancelled
|
$ | 2,133 | $ | -- | ||||
|
Common stock issued for the conversion of preferred stock
|
-- | 60,000 | ||||||
|
Common stock issued for conversion of debt
|
-- | 59,000 | ||||||
|
Related party deferred revenue written-off against carrying value of
equity method investment in related party
|
-- | 193,219 | ||||||
|
Three Months Ended June 30, 2012
|
||||||||||||||||
|
Adjustments for
|
Adjustments for
|
|||||||||||||||
|
Change in
|
Correction of
|
|||||||||||||||
|
As Previously
|
Accounting
|
Prior Year
|
As Revised
|
|||||||||||||
|
Reported
|
Principle
|
Information
|
and Restated
|
|||||||||||||
|
Unrealized gain (loss) on marketable
|
||||||||||||||||
|
securities
|
$ | 32,400 | $ | (30,000 | ) | $ | - | $ | 2,400 | |||||||
|
Unrealized gain (loss) on marketable
|
||||||||||||||||
|
securities held in related party
|
(430,000 | ) | 430,000 | - | - | |||||||||||
|
Loss on equity method investment in
|
||||||||||||||||
|
related party
|
- | (33,652 | ) | - | (33,652 | ) | ||||||||||
|
Total other expenses
|
(420,465 | ) | 366,348 | - | (54,117 | ) | ||||||||||
|
Net loss
|
$ | (455,607 | ) | $ | 366,348 | $ | - | $ | (89,259 | ) | ||||||
|
Six Months Ended June 30, 2012
|
||||||||||||||||
|
Adjustments for
|
Adjustments for
|
|||||||||||||||
|
Change in
|
Correction of
|
|||||||||||||||
|
As Previously
|
Accounting
|
Prior Year
|
As Revised
|
|||||||||||||
|
Reported
|
Principle
|
Information
|
and Restated
|
|||||||||||||
|
Revenue
|
$ | 215,714 | $ | - | $ | (193,219 | ) | $ | 22,495 | |||||||
|
Unrealized gain (loss) on marketable
|
||||||||||||||||
|
securities held in related party
|
(430,000 | ) | 430,000 | - | - | |||||||||||
|
Impairment of equity method
|
||||||||||||||||
|
investment in related party
|
- | - | (172,617 | ) | (172,617 | ) | ||||||||||
|
Loss on equity method investment in
|
||||||||||||||||
|
related party
|
- | (47,681 | ) | - | (47,681 | ) | ||||||||||
|
Total other expenses
|
(426,249 | ) | 382,319 | (172,617 | ) | (216,547 | ) | |||||||||
|
Net loss
|
$ | (538,817 | ) | $ | 382,319 | $ | (365,836 | ) | $ | (522,334 | ) | |||||
|
Six Months Ended June 30, 2012
|
||||||||||||||||
|
Adjustments for
|
Adjustments for
|
|||||||||||||||
|
Change in
|
Correction of
|
|||||||||||||||
|
As Previously
|
Accounting
|
Prior Year
|
As Revised
|
|||||||||||||
|
Reported
|
Principle
|
Information
|
and Restated
|
|||||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||||||
|
Net loss
|
$ | (538,817 | ) | $ | 382,319 | $ | (365,836 | ) | $ | (522,334 | ) | |||||
|
Adjustments to reconcile net loss to net
|
||||||||||||||||
|
cash used in operating activities:
|
||||||||||||||||
|
Unrealized loss (gain) on marketable
|
||||||||||||||||
|
securities held in related party
|
430,000 | (430,000 | ) | - | - | |||||||||||
|
Impairment of equity method
|
||||||||||||||||
|
investments in related party
|
- | - | 172,617 | 172,617 | ||||||||||||
|
Loss on equity method investments
|
||||||||||||||||
|
in related party
|
- | 47,681 | - | 47,681 | ||||||||||||
|
Changes in operating assets and
|
||||||||||||||||
|
liabilities:
|
||||||||||||||||
|
Deferred revenue from related party
|
(193,219 | ) | - | 193,219 | - | |||||||||||
|
Noncash Investing and Financing Activities:
|
||||||||||||||||
|
Related party deferred revenue written-
|
||||||||||||||||
|
off against carrying value of equity
|
||||||||||||||||
|
method investment in related party
|
$ | - | $ | - | $ | 193,219 | $ | 193,219 | ||||||||
|
Description
|
Quoted Prices in
Active Markets for
|
Significant
Other
|
Significant
Unobservable
|
Total
Balance as of
|
||||||||||||
|
Assets:
|
||||||||||||||||
|
Marketable securities
|
$ | 87,750 | $ | - | $ | - | $ | 87,750 | ||||||||
|
Description
|
Quoted Prices in
Active Markets for
|
Significant
Other
|
Significant
Unobservable
|
Total
Balance as of
|
||||||||||||
|
Assets:
|
||||||||||||||||
|
Marketable securities
|
$ | 105,000 | $ | - | $ | - | $ | 105,000 | ||||||||
|
EXHIBIT 31.1
|
Certification of Principal Executive Officer
|
|
|
EXHIBIT 31.2
|
Certification of Principal Financial Officer
|
|
|
EXHIBIT 32.1
|
Certification of Compliance to Sarbanes-Oxley
|
|
|
EXHIBIT 32.2
|
Certification of Compliance to Sarbanes-Oxley
|
|
101.INS **
|
XBRL Instance Document
|
|
|
101.SCH **
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL **
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF **
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB **
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE **
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
| CROWN EQUITY HOLDINGS INC. | |||
|
Date August 16, 2013
|
By:
|
/s/ Kenneth Bosket | |
| Kenneth Bosket, CEO | |||
|
By:
|
/s/ Lowell Holden | ||
| Lowell Holden, CFO | |||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|